Funding for this research was provided by:
National Human Genome Research Institute (R03HG008809)
Received: 4 April 2017
Accepted: 2 January 2018
First Online: 30 January 2018
Ethics approval and consent to participate
: The Institutional Review Board at the Icahn School of Medicine at Mount Sinai determined this study (#12–1273) to be exempt.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.